Search Results
Sarah E McClelland
Sarah E McClelland
Barts Cancer Institute, Queen Mary University of London, London, UK
Search for other papers by Sarah E McClelland in
Google Scholar
PubMed
Search for other papers by Sarah E McClelland in
Google Scholar
PubMed
chromosome segregation errors ( Fig. 1A ) increase genetic heterogeneity between tumour cells at each cell cycle, allowing rapid evolution of tumour genomes and presenting a challenge to cancer patient treatment (see below). Chromosome segregation errors can
Eilon Krashin
Eilon Krashin
Translational Oncology Laboratory, Meir Medical Center, Kfar-Saba, Israel
Department of Human Molecular Genetics and Biochemistry, Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel
Search for other papers by Eilon Krashin in
Google Scholar
PubMed
Department of Human Molecular Genetics and Biochemistry, Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel
Search for other papers by Eilon Krashin in
Google Scholar
PubMed
Barbara Silverman
Barbara Silverman
Israel National Cancer Registry, Ministry of Health, Gertner Institute, Sheba Medical Center, Tel Hashomer, Israel
School of Public Health, Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel
Search for other papers by Barbara Silverman in
Google Scholar
PubMed
School of Public Health, Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel
Search for other papers by Barbara Silverman in
Google Scholar
PubMed
David M Steinberg
David M Steinberg
Department of Statistics and Operations Research, Tel Aviv University, Tel Aviv, Israel
Search for other papers by David M Steinberg in
Google Scholar
PubMed
Search for other papers by David M Steinberg in
Google Scholar
PubMed
Daniel Yekutieli
Daniel Yekutieli
Department of Statistics and Operations Research, Tel Aviv University, Tel Aviv, Israel
Search for other papers by Daniel Yekutieli in
Google Scholar
PubMed
Search for other papers by Daniel Yekutieli in
Google Scholar
PubMed
Shmuel Giveon
Shmuel Giveon
Clalit Health Services, Tel Aviv, Israel
Search for other papers by Shmuel Giveon in
Google Scholar
PubMed
Search for other papers by Shmuel Giveon in
Google Scholar
PubMed
Offer Fabian
Offer Fabian
Translational Oncology Laboratory, Meir Medical Center, Kfar-Saba, Israel
Search for other papers by Offer Fabian in
Google Scholar
PubMed
Search for other papers by Offer Fabian in
Google Scholar
PubMed
Aleck Hercbergs
Aleck Hercbergs
Department of Radiation Oncology, Cleveland Clinic, Cleveland, Ohio, USA
Search for other papers by Aleck Hercbergs in
Google Scholar
PubMed
Search for other papers by Aleck Hercbergs in
Google Scholar
PubMed
Paul J Davis
Paul J Davis
Department of Medicine, Albany Medical College, Albany, New York, USA
Search for other papers by Paul J Davis in
Google Scholar
PubMed
Search for other papers by Paul J Davis in
Google Scholar
PubMed
Martin Ellis
Martin Ellis
Translational Oncology Laboratory, Meir Medical Center, Kfar-Saba, Israel
Hematology Institute and Blood Bank, Meir Medical Center, Kfar-Saba, Israel
Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel
Search for other papers by Martin Ellis in
Google Scholar
PubMed
Hematology Institute and Blood Bank, Meir Medical Center, Kfar-Saba, Israel
Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel
Search for other papers by Martin Ellis in
Google Scholar
PubMed
Osnat Ashur-Fabian
Osnat Ashur-Fabian
Translational Oncology Laboratory, Meir Medical Center, Kfar-Saba, Israel
Department of Human Molecular Genetics and Biochemistry, Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel
Search for other papers by Osnat Ashur-Fabian in
Google Scholar
PubMed
Department of Human Molecular Genetics and Biochemistry, Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel
Search for other papers by Osnat Ashur-Fabian in
Google Scholar
PubMed
Introduction Thyroid hormones are central players in normal development ( Moeller & Fuhrer 2013 ). Several population-based studies have demonstrated opposing effects of thyroid hormone dysfunction on cancer risk. Specifically, hyperthyroidism
Isabel Mayayo-Peralta
Isabel Mayayo-Peralta
Division of Oncogenomics, Oncode Institute, the Netherlands Cancer Institute, Amsterdam, the Netherlands
Search for other papers by Isabel Mayayo-Peralta in
Google Scholar
PubMed
Search for other papers by Isabel Mayayo-Peralta in
Google Scholar
PubMed
Wilbert Zwart
Wilbert Zwart
Division of Oncogenomics, Oncode Institute, the Netherlands Cancer Institute, Amsterdam, the Netherlands
Laboratory of Chemical Biology and Institute for Complex Molecular Systems, Department of Biomedical Engineering, Eindhoven University of Technology, Eindhoven, the Netherlands
Search for other papers by Wilbert Zwart in
Google Scholar
PubMed
Laboratory of Chemical Biology and Institute for Complex Molecular Systems, Department of Biomedical Engineering, Eindhoven University of Technology, Eindhoven, the Netherlands
Search for other papers by Wilbert Zwart in
Google Scholar
PubMed
Stefan Prekovic
Stefan Prekovic
Division of Oncogenomics, Oncode Institute, the Netherlands Cancer Institute, Amsterdam, the Netherlands
Search for other papers by Stefan Prekovic in
Google Scholar
PubMed
Search for other papers by Stefan Prekovic in
Google Scholar
PubMed
system, metabolism, and brain. In addition to that, GR activity or lack thereof has been linked to various aspects of cancer biology; however, its role in cancer seems to be complex and highly context-dependent, as GR has been proposed to be both a tumor
Adam W Nelson
Adam W Nelson
Cancer Research UK Cambridge Institute, University of Cambridge, Robinson Way, Cambridge CB2 0RE, UK
Department of Urology Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 0QQ, UK
Dame Roma Mitchell Cancer Research Laboratories Faculty of Health Sciences, School of Medicine, The University of Adelaide, Level 4, Hanson Institute Building, DX Number 650 801, Adelaide, South Australia 5000, Australia
Department of Oncology University of Cambridge, Cambridge CB2 2QQ, UK
Cancer Research UK Cambridge Institute, University of Cambridge, Robinson Way, Cambridge CB2 0RE, UK
Department of Urology Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 0QQ, UK
Dame Roma Mitchell Cancer Research Laboratories Faculty of Health Sciences, School of Medicine, The University of Adelaide, Level 4, Hanson Institute Building, DX Number 650 801, Adelaide, South Australia 5000, Australia
Department of Oncology University of Cambridge, Cambridge CB2 2QQ, UK
Search for other papers by Adam W Nelson in
Google Scholar
PubMed
Department of Urology Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 0QQ, UK
Dame Roma Mitchell Cancer Research Laboratories Faculty of Health Sciences, School of Medicine, The University of Adelaide, Level 4, Hanson Institute Building, DX Number 650 801, Adelaide, South Australia 5000, Australia
Department of Oncology University of Cambridge, Cambridge CB2 2QQ, UK
Cancer Research UK Cambridge Institute, University of Cambridge, Robinson Way, Cambridge CB2 0RE, UK
Department of Urology Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 0QQ, UK
Dame Roma Mitchell Cancer Research Laboratories Faculty of Health Sciences, School of Medicine, The University of Adelaide, Level 4, Hanson Institute Building, DX Number 650 801, Adelaide, South Australia 5000, Australia
Department of Oncology University of Cambridge, Cambridge CB2 2QQ, UK
Search for other papers by Adam W Nelson in
Google Scholar
PubMed
Wayne D Tilley
Wayne D Tilley
Cancer Research UK Cambridge Institute, University of Cambridge, Robinson Way, Cambridge CB2 0RE, UK
Department of Urology Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 0QQ, UK
Dame Roma Mitchell Cancer Research Laboratories Faculty of Health Sciences, School of Medicine, The University of Adelaide, Level 4, Hanson Institute Building, DX Number 650 801, Adelaide, South Australia 5000, Australia
Department of Oncology University of Cambridge, Cambridge CB2 2QQ, UK
Cancer Research UK Cambridge Institute, University of Cambridge, Robinson Way, Cambridge CB2 0RE, UK
Department of Urology Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 0QQ, UK
Dame Roma Mitchell Cancer Research Laboratories Faculty of Health Sciences, School of Medicine, The University of Adelaide, Level 4, Hanson Institute Building, DX Number 650 801, Adelaide, South Australia 5000, Australia
Department of Oncology University of Cambridge, Cambridge CB2 2QQ, UK
Search for other papers by Wayne D Tilley in
Google Scholar
PubMed
Department of Urology Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 0QQ, UK
Dame Roma Mitchell Cancer Research Laboratories Faculty of Health Sciences, School of Medicine, The University of Adelaide, Level 4, Hanson Institute Building, DX Number 650 801, Adelaide, South Australia 5000, Australia
Department of Oncology University of Cambridge, Cambridge CB2 2QQ, UK
Cancer Research UK Cambridge Institute, University of Cambridge, Robinson Way, Cambridge CB2 0RE, UK
Department of Urology Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 0QQ, UK
Dame Roma Mitchell Cancer Research Laboratories Faculty of Health Sciences, School of Medicine, The University of Adelaide, Level 4, Hanson Institute Building, DX Number 650 801, Adelaide, South Australia 5000, Australia
Department of Oncology University of Cambridge, Cambridge CB2 2QQ, UK
Search for other papers by Wayne D Tilley in
Google Scholar
PubMed
David E Neal
David E Neal
Cancer Research UK Cambridge Institute, University of Cambridge, Robinson Way, Cambridge CB2 0RE, UK
Department of Urology Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 0QQ, UK
Dame Roma Mitchell Cancer Research Laboratories Faculty of Health Sciences, School of Medicine, The University of Adelaide, Level 4, Hanson Institute Building, DX Number 650 801, Adelaide, South Australia 5000, Australia
Department of Oncology University of Cambridge, Cambridge CB2 2QQ, UK
Cancer Research UK Cambridge Institute, University of Cambridge, Robinson Way, Cambridge CB2 0RE, UK
Department of Urology Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 0QQ, UK
Dame Roma Mitchell Cancer Research Laboratories Faculty of Health Sciences, School of Medicine, The University of Adelaide, Level 4, Hanson Institute Building, DX Number 650 801, Adelaide, South Australia 5000, Australia
Department of Oncology University of Cambridge, Cambridge CB2 2QQ, UK
Cancer Research UK Cambridge Institute, University of Cambridge, Robinson Way, Cambridge CB2 0RE, UK
Department of Urology Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 0QQ, UK
Dame Roma Mitchell Cancer Research Laboratories Faculty of Health Sciences, School of Medicine, The University of Adelaide, Level 4, Hanson Institute Building, DX Number 650 801, Adelaide, South Australia 5000, Australia
Department of Oncology University of Cambridge, Cambridge CB2 2QQ, UK
Search for other papers by David E Neal in
Google Scholar
PubMed
Department of Urology Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 0QQ, UK
Dame Roma Mitchell Cancer Research Laboratories Faculty of Health Sciences, School of Medicine, The University of Adelaide, Level 4, Hanson Institute Building, DX Number 650 801, Adelaide, South Australia 5000, Australia
Department of Oncology University of Cambridge, Cambridge CB2 2QQ, UK
Cancer Research UK Cambridge Institute, University of Cambridge, Robinson Way, Cambridge CB2 0RE, UK
Department of Urology Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 0QQ, UK
Dame Roma Mitchell Cancer Research Laboratories Faculty of Health Sciences, School of Medicine, The University of Adelaide, Level 4, Hanson Institute Building, DX Number 650 801, Adelaide, South Australia 5000, Australia
Department of Oncology University of Cambridge, Cambridge CB2 2QQ, UK
Cancer Research UK Cambridge Institute, University of Cambridge, Robinson Way, Cambridge CB2 0RE, UK
Department of Urology Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 0QQ, UK
Dame Roma Mitchell Cancer Research Laboratories Faculty of Health Sciences, School of Medicine, The University of Adelaide, Level 4, Hanson Institute Building, DX Number 650 801, Adelaide, South Australia 5000, Australia
Department of Oncology University of Cambridge, Cambridge CB2 2QQ, UK
Search for other papers by David E Neal in
Google Scholar
PubMed
Jason S Carroll
Jason S Carroll
Cancer Research UK Cambridge Institute, University of Cambridge, Robinson Way, Cambridge CB2 0RE, UK
Department of Urology Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 0QQ, UK
Dame Roma Mitchell Cancer Research Laboratories Faculty of Health Sciences, School of Medicine, The University of Adelaide, Level 4, Hanson Institute Building, DX Number 650 801, Adelaide, South Australia 5000, Australia
Department of Oncology University of Cambridge, Cambridge CB2 2QQ, UK
Cancer Research UK Cambridge Institute, University of Cambridge, Robinson Way, Cambridge CB2 0RE, UK
Department of Urology Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 0QQ, UK
Dame Roma Mitchell Cancer Research Laboratories Faculty of Health Sciences, School of Medicine, The University of Adelaide, Level 4, Hanson Institute Building, DX Number 650 801, Adelaide, South Australia 5000, Australia
Department of Oncology University of Cambridge, Cambridge CB2 2QQ, UK
Search for other papers by Jason S Carroll in
Google Scholar
PubMed
Department of Urology Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 0QQ, UK
Dame Roma Mitchell Cancer Research Laboratories Faculty of Health Sciences, School of Medicine, The University of Adelaide, Level 4, Hanson Institute Building, DX Number 650 801, Adelaide, South Australia 5000, Australia
Department of Oncology University of Cambridge, Cambridge CB2 2QQ, UK
Cancer Research UK Cambridge Institute, University of Cambridge, Robinson Way, Cambridge CB2 0RE, UK
Department of Urology Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 0QQ, UK
Dame Roma Mitchell Cancer Research Laboratories Faculty of Health Sciences, School of Medicine, The University of Adelaide, Level 4, Hanson Institute Building, DX Number 650 801, Adelaide, South Australia 5000, Australia
Department of Oncology University of Cambridge, Cambridge CB2 2QQ, UK
Search for other papers by Jason S Carroll in
Google Scholar
PubMed
Introduction Prostate cancer is the commonest, non-cutaneous cancer in men, affecting 214 per 1000 European men. It is the second commonest cause of cancer death, accounting for 15% of all male cancers in developed countries ( Heidenreich et al
Kristina Warton
Kristina Warton
Garvan Institute of Medical Research, Chris O'Brien Lifehouse, The Kinghorn Cancer Centre and St Vincent's Clinical School, 370 Victoria Street, Darlinghurst, Sydeny, New South Wales, Australia
Search for other papers by Kristina Warton in
Google Scholar
PubMed
Search for other papers by Kristina Warton in
Google Scholar
PubMed
Kate L Mahon
Kate L Mahon
Garvan Institute of Medical Research, Chris O'Brien Lifehouse, The Kinghorn Cancer Centre and St Vincent's Clinical School, 370 Victoria Street, Darlinghurst, Sydeny, New South Wales, Australia
Garvan Institute of Medical Research, Chris O'Brien Lifehouse, The Kinghorn Cancer Centre and St Vincent's Clinical School, 370 Victoria Street, Darlinghurst, Sydeny, New South Wales, Australia
Search for other papers by Kate L Mahon in
Google Scholar
PubMed
Garvan Institute of Medical Research, Chris O'Brien Lifehouse, The Kinghorn Cancer Centre and St Vincent's Clinical School, 370 Victoria Street, Darlinghurst, Sydeny, New South Wales, Australia
Search for other papers by Kate L Mahon in
Google Scholar
PubMed
Goli Samimi
Goli Samimi
Garvan Institute of Medical Research, Chris O'Brien Lifehouse, The Kinghorn Cancer Centre and St Vincent's Clinical School, 370 Victoria Street, Darlinghurst, Sydeny, New South Wales, Australia
Search for other papers by Goli Samimi in
Google Scholar
PubMed
Search for other papers by Goli Samimi in
Google Scholar
PubMed
Methylated circulating DNA in cancer prognosis and monitoring Genomics is anticipated to bring major improvements in the treatment of cancer patients. The capacity to quickly and relatively inexpensively sequence tumor DNA on a genome-wide scale
Yue Wang
Yue Wang
Liggins Institute, University of Auckland, Auckland, New Zealand
Maurice Wilkins Centre for Molecular Biodiscovery, Auckland, New Zealand
Search for other papers by Yue Wang in
Google Scholar
PubMed
Maurice Wilkins Centre for Molecular Biodiscovery, Auckland, New Zealand
Search for other papers by Yue Wang in
Google Scholar
PubMed
Stephen M F Jamieson
Stephen M F Jamieson
Maurice Wilkins Centre for Molecular Biodiscovery, Auckland, New Zealand
Auckland Cancer Society Research Centre, University of Auckland, Auckland, New Zealand
Department of Pharmacology and Clinical Pharmacology, University of Auckland, Auckland, New Zealand
Search for other papers by Stephen M F Jamieson in
Google Scholar
PubMed
Auckland Cancer Society Research Centre, University of Auckland, Auckland, New Zealand
Department of Pharmacology and Clinical Pharmacology, University of Auckland, Auckland, New Zealand
Search for other papers by Stephen M F Jamieson in
Google Scholar
PubMed
Jo K Perry
Jo K Perry
Liggins Institute, University of Auckland, Auckland, New Zealand
Maurice Wilkins Centre for Molecular Biodiscovery, Auckland, New Zealand
Search for other papers by Jo K Perry in
Google Scholar
PubMed
Maurice Wilkins Centre for Molecular Biodiscovery, Auckland, New Zealand
Search for other papers by Jo K Perry in
Google Scholar
PubMed
Introduction Observations in humans and animals with elevated or disrupted growth hormone (GH) signalling clearly support a role for GH in cancer development ( Guevara-Aguirre et al. 2020 , Werner et al. 2020 , Duran-Ortiz et al. 2021
Zara Zelenko
Zara Zelenko
Division of Endocrinology, Diabetes and Bone Diseases, Icahn School of Medicine at Mount Sinai, New York, New York, USA
Search for other papers by Zara Zelenko in
Google Scholar
PubMed
Search for other papers by Zara Zelenko in
Google Scholar
PubMed
Emily Jane Gallagher
Emily Jane Gallagher
Division of Endocrinology, Diabetes and Bone Diseases, Icahn School of Medicine at Mount Sinai, New York, New York, USA
Search for other papers by Emily Jane Gallagher in
Google Scholar
PubMed
Search for other papers by Emily Jane Gallagher in
Google Scholar
PubMed
Irini Markella Antoniou
Irini Markella Antoniou
Division of Endocrinology, Diabetes and Bone Diseases, Icahn School of Medicine at Mount Sinai, New York, New York, USA
Search for other papers by Irini Markella Antoniou in
Google Scholar
PubMed
Search for other papers by Irini Markella Antoniou in
Google Scholar
PubMed
Deepali Sachdev
Deepali Sachdev
Department of Medicine and Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota, USA
Search for other papers by Deepali Sachdev in
Google Scholar
PubMed
Search for other papers by Deepali Sachdev in
Google Scholar
PubMed
Anupma Nayak
Anupma Nayak
Department of Pathology and Laboratory Medicine, The Mount Sinai Hospital and Icahn School of Medicine at Mount Sinai, New York, New York, USA
Search for other papers by Anupma Nayak in
Google Scholar
PubMed
Search for other papers by Anupma Nayak in
Google Scholar
PubMed
Douglas Yee
Douglas Yee
Department of Medicine and Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota, USA
Search for other papers by Douglas Yee in
Google Scholar
PubMed
Search for other papers by Douglas Yee in
Google Scholar
PubMed
Derek LeRoith
Derek LeRoith
Division of Endocrinology, Diabetes and Bone Diseases, Icahn School of Medicine at Mount Sinai, New York, New York, USA
Search for other papers by Derek LeRoith in
Google Scholar
PubMed
Search for other papers by Derek LeRoith in
Google Scholar
PubMed
Introduction Both obesity and type 2 diabetes (T2D) are associated with increased cancer risk and cancer-related mortality ( Haslam & James 2005 , Onitilo et al . 2012 , Zhang et al . 2012 ). Obesity and T2D may contribute to cancer
Thi-Van-Trinh Tran
Thi-Van-Trinh Tran
Cancer and Radiation Group, Center for Research in Epidemiology and Population Health, INSERM U1018, Paris Sud-Paris Saclay University, Gustave Roussy, Villejuif, France
Search for other papers by Thi-Van-Trinh Tran in
Google Scholar
PubMed
Search for other papers by Thi-Van-Trinh Tran in
Google Scholar
PubMed
Cari M Kitahara
Cari M Kitahara
Radiation Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA
Search for other papers by Cari M Kitahara in
Google Scholar
PubMed
Search for other papers by Cari M Kitahara in
Google Scholar
PubMed
Florent de Vathaire
Florent de Vathaire
Cancer and Radiation Group, Center for Research in Epidemiology and Population Health, INSERM U1018, Paris Sud-Paris Saclay University, Gustave Roussy, Villejuif, France
Search for other papers by Florent de Vathaire in
Google Scholar
PubMed
Search for other papers by Florent de Vathaire in
Google Scholar
PubMed
Marie-Christine Boutron-Ruault
Marie-Christine Boutron-Ruault
Health Across Generations Group, Center for Research in Epidemiology and Population Health, INSERM U1018, Paris Sud-Paris Saclay University, Gustave Roussy, Villejuif, France
Search for other papers by Marie-Christine Boutron-Ruault in
Google Scholar
PubMed
Search for other papers by Marie-Christine Boutron-Ruault in
Google Scholar
PubMed
Neige Journy
Neige Journy
Cancer and Radiation Group, Center for Research in Epidemiology and Population Health, INSERM U1018, Paris Sud-Paris Saclay University, Gustave Roussy, Villejuif, France
Search for other papers by Neige Journy in
Google Scholar
PubMed
Search for other papers by Neige Journy in
Google Scholar
PubMed
, thyroid dysfunction is associated with obesity ( Laurberg et al. 2012 ), diabetes mellitus ( Brandt et al. 2013 ), and vascular diseases ( Brandt et al. 2013 ), which have been linked to an increased cancer risk or shared common risk factors. However
Catherine M Olsen
Catherine M Olsen
Cancer and Population Studies Group, School of Population Health, Queensland Institute of Medical Research, Brisbane, 4029, Australia
Cancer and Population Studies Group, School of Population Health, Queensland Institute of Medical Research, Brisbane, 4029, Australia
Search for other papers by Catherine M Olsen in
Google Scholar
PubMed
Cancer and Population Studies Group, School of Population Health, Queensland Institute of Medical Research, Brisbane, 4029, Australia
Search for other papers by Catherine M Olsen in
Google Scholar
PubMed
Adèle C Green
Adèle C Green
Cancer and Population Studies Group, School of Population Health, Queensland Institute of Medical Research, Brisbane, 4029, Australia
Search for other papers by Adèle C Green in
Google Scholar
PubMed
Search for other papers by Adèle C Green in
Google Scholar
PubMed
Christina M Nagle
Christina M Nagle
Cancer and Population Studies Group, School of Population Health, Queensland Institute of Medical Research, Brisbane, 4029, Australia
Search for other papers by Christina M Nagle in
Google Scholar
PubMed
Search for other papers by Christina M Nagle in
Google Scholar
PubMed
Susan J Jordan
Susan J Jordan
Cancer and Population Studies Group, School of Population Health, Queensland Institute of Medical Research, Brisbane, 4029, Australia
Cancer and Population Studies Group, School of Population Health, Queensland Institute of Medical Research, Brisbane, 4029, Australia
Search for other papers by Susan J Jordan in
Google Scholar
PubMed
Cancer and Population Studies Group, School of Population Health, Queensland Institute of Medical Research, Brisbane, 4029, Australia
Search for other papers by Susan J Jordan in
Google Scholar
PubMed
David C Whiteman
David C Whiteman
Cancer and Population Studies Group, School of Population Health, Queensland Institute of Medical Research, Brisbane, 4029, Australia
Search for other papers by David C Whiteman in
Google Scholar
PubMed
Search for other papers by David C Whiteman in
Google Scholar
PubMed
Christopher J Bain
Christopher J Bain
Cancer and Population Studies Group, School of Population Health, Queensland Institute of Medical Research, Brisbane, 4029, Australia
Search for other papers by Christopher J Bain in
Google Scholar
PubMed
Search for other papers by Christopher J Bain in
Google Scholar
PubMed
Penelope M Webb
Penelope M Webb
Cancer and Population Studies Group, School of Population Health, Queensland Institute of Medical Research, Brisbane, 4029, Australia
Search for other papers by Penelope M Webb in
Google Scholar
PubMed
Search for other papers by Penelope M Webb in
Google Scholar
PubMed
on behalf of the Australian Cancer Study Group (Ovarian Cancer) and the Australian Ovarian Cancer Study Group
on behalf of the Australian Cancer Study Group (Ovarian Cancer) and the Australian Ovarian Cancer Study Group
Search for other papers by on behalf of the Australian Cancer Study Group (Ovarian Cancer) and the Australian Ovarian Cancer Study Group in
Google Scholar
PubMed
Search for other papers by on behalf of the Australian Cancer Study Group (Ovarian Cancer) and the Australian Ovarian Cancer Study Group in
Google Scholar
PubMed
Introduction In 1998, Risch (1998) put forward a hypothesis for the pathogenesis of ovarian cancer relating to the role of androgens in stimulating epithelial cell proliferation. Although widely discussed in the aetiologic literature, there is a
Sakine Sever
Sakine Sever
Division of Endocrinology, Diabetes, and Metabolism, Baylor College of Medicine, Alkek Building for Biomedical Research, Houston, Texas, USA
Search for other papers by Sakine Sever in
Google Scholar
PubMed
Search for other papers by Sakine Sever in
Google Scholar
PubMed
Donna L White
Donna L White
Section of Gastroenterology and Hepatology, Baylor College of Medicine Medical Center, Houston, Texas, USA
Clinical Epidemiology and Comparative Effectiveness Program, Section of Health Services Research (IQuESt), Michael E. DeBakey Veterans Affairs Medical Center, HSR&D Center of Innovation (152), Houston, Texas, USA
Texas Medical Center Digestive Disease Center, Baylor College of Medicine, Houston, Texas, USA
Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas, USA
Center for Translational Research on Inflammatory Diseases (CTRID), Michael E. DeBakey Veterans Affairs Medical Center, Houston, Texas, USA
Search for other papers by Donna L White in
Google Scholar
PubMed
Clinical Epidemiology and Comparative Effectiveness Program, Section of Health Services Research (IQuESt), Michael E. DeBakey Veterans Affairs Medical Center, HSR&D Center of Innovation (152), Houston, Texas, USA
Texas Medical Center Digestive Disease Center, Baylor College of Medicine, Houston, Texas, USA
Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas, USA
Center for Translational Research on Inflammatory Diseases (CTRID), Michael E. DeBakey Veterans Affairs Medical Center, Houston, Texas, USA
Search for other papers by Donna L White in
Google Scholar
PubMed
José M Garcia
José M Garcia
Division of Endocrinology, Diabetes, and Metabolism, Baylor College of Medicine, Alkek Building for Biomedical Research, Houston, Texas, USA
Center for Translational Research on Inflammatory Diseases (CTRID), Michael E. DeBakey Veterans Affairs Medical Center, Houston, Texas, USA
Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas, USA
Huffington Center on Aging, Baylor College of Medicine, Houston, Texas, USA
Geriatrics Research Education and Clinical Center, Veterans Affairs Puget Sound Health Care System and University of Washington, Seattle, Washington, USA
Search for other papers by José M Garcia in
Google Scholar
PubMed
Center for Translational Research on Inflammatory Diseases (CTRID), Michael E. DeBakey Veterans Affairs Medical Center, Houston, Texas, USA
Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas, USA
Huffington Center on Aging, Baylor College of Medicine, Houston, Texas, USA
Geriatrics Research Education and Clinical Center, Veterans Affairs Puget Sound Health Care System and University of Washington, Seattle, Washington, USA
Search for other papers by José M Garcia in
Google Scholar
PubMed
conditions such as eating/wasting disorders and cachexia related to cancer and other conditions, such as cardiovascular disease and chronic obstructive pulmonary disease ( Nagaya et al . 2004 , 2005 , Strasser et al . 2008 , Müller et al . 2010 , Ali
